Luciana Molinero to Programmed Cell Death 1 Receptor
This is a "connection" page, showing publications Luciana Molinero has written about Programmed Cell Death 1 Receptor.
Connection Strength
0.038
-
Safety, clinical activity and biomarker assessments of atezolizumab from a Phase I study in advanced/recurrent ovarian and uterine cancers. Gynecol Oncol. 2019 08; 154(2):314-322.
Score: 0.038